BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1439000)

  • 1. [The significance of the AMES and the NTM systems to determine the prognosis in patients with differentiated cancer of the thyroid].
    García de Paredes G
    Rev Med Panama; 1992 Sep; 17(3):155-62. PubMed ID: 1439000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
    Shaha AR
    Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States.
    Haigh PI; Urbach DR; Rotstein LE
    Surgery; 2004 Sep; 136(3):609-16. PubMed ID: 15349109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.
    Yildirim E
    J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node metastases in differentiated thyroid cancer under 2 cm.
    Reddy RM; Grigsby PW; Moley JF; Hall BL
    Surgery; 2006 Dec; 140(6):1050-4; discussion 1054-5. PubMed ID: 17188156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.
    Voutilainen PE; Siironen P; Franssila KO; Sivula A; Haapiainen RK; Haglund CH
    Anticancer Res; 2003; 23(5b):4283-8. PubMed ID: 14666639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of thyroid tumor aggressiveness.
    Clark OH
    West J Med; 1996 Sep; 165(3):131-8. PubMed ID: 8909165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic considerations and operative strategy in papillary thyroid carcinoma: arguments against the routine performance of total thyroidectomy.
    Cohn KH; Bäckdahl M; Forsslund G; Auer G; Zetterberg A; Lundell G; Granberg PO; Löwhagen T; Willems JS; Cady B
    Surgery; 1984 Dec; 96(6):957-71. PubMed ID: 6505969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lymph node dissection in non-medullary differentiated thyroid carcinoma].
    Mathonnet M
    Ann Chir; 2006; 131(6-7):361-8. PubMed ID: 16329987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The surgical treatment of well-differentiated carcinoma of the thyroid.
    Ontai S; Straehley CJ
    Am Surg; 1985 Nov; 51(11):653-7. PubMed ID: 4062059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma.
    Marchesi M; Biffoni M; Biancari F; Berni A; Campana FP
    Eur J Surg Suppl; 2003 Jul; (588):46-50. PubMed ID: 15200043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
    Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
    Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
    Liu WS; Qi YF; Tang PZ
    Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective surgery and adjuvant therapy based on risk classifications of well-differentiated thyroid cancer.
    Cross S; Wei JP; Kim S; Brams DM
    J Surg Oncol; 2006 Dec; 94(8):678-82. PubMed ID: 17131414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.
    La Quaglia MP; Black T; Holcomb GW; Sklar C; Azizkhan RG; Haase GM; Newman KD
    J Pediatr Surg; 2000 Jun; 35(6):955-9; discussion 960. PubMed ID: 10873043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer.
    Haigh PI; Urbach DR; Rotstein LE
    Ann Surg Oncol; 2005 Jan; 12(1):81-9. PubMed ID: 15827782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus conference on well-differentiated thyroid cancer: a summary.
    Pasieka JL; Rotstein LE
    Can J Surg; 1993 Aug; 36(4):298-301. PubMed ID: 8370008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.